Navigation Links
Regulus Therapeutics to Present New Advancements in microRNA Therapeutics for Treatment of Metabolic Diseases and Cancer
Date:9/8/2011

In addition, Regulus collaborators Markus Stoffel, Ph.D., M.D. of ETH Zurich will be chairing a session titled "Targeting microRNA," and Thomas Thum, M.D., Ph.D. of Medical School Hannover, Germany will be presenting a talk on "Therapeutic targeting of individual cardiac cell types by microRNA antagonists."

Regulus is advancing multiple microRNA therapeutic programs to the clinic in the areas of fibrosis, immuno-inflammatory disease, metabolic disease, and oncology.

About microRNAs

The discovery of microRNA in humans during the last decade is one of the most exciting scientific breakthroughs in recent history. microRNAs are small RNA molecules, typically 20 to 25 nucleotides in length, that do not encode proteins but instead regulate gene expression. More than 700 microRNAs have been identified in the human genome, and over one-third of all human genes are believed to be regulated by microRNAs. A single microRNA can regulate entire networks of genes. As such, these molecules are considered master regulators of the human genome. microRNAs have been shown to play an integral role in numerous biological processes, including the immune response, cell-cycle control, metabolism, viral replication, stem cell differentiation and human development. Most microRNAs are conserved across multiple species, indicating the evolutionary importance of these molecules as modulators of critical biological pathways. Indeed, microRNA expression, or function, has been shown to be significantly altered in many disease states, including cancer, heart failure and viral infections. Targeting microRNAs with anti-miRs, antisense oligonucleotide inhibitors of microRNAs, or miR-mimics, double-stranded oligonucleotides to replace microRNA function opens potential for a novel class of therapeutics and offers a unique approach to treating disease by modulating entire biological pathways. To learn more abou
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Regulus Therapeutics and Collaborators from NYU Langone Medical Center Publish New Data Demonstrating Clearance of Cholesterol from Bloodstream and Reduction of Atherosclerotic Plaques through Inhibition of microRNA-33
2. Regulus Therapeutics Appoints Gregory Hannon, Ph.D. to Scientific Advisory Board
3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
8. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 19, 2014 ... ) has announced the addition of the ... report to their offering.      ... study of chromosomes using molecular biology to ... and chromosomes. It plays a crucial role ...
(Date:9/18/2014)... September 18, 2014 ... ) has announced the addition of the  ...  report to their offering.       ... worldwide markets for Sugar Alcohols in Million ... & Confectionery, Pharmaceuticals, Cosmetics, Oral-Care Products, and ...
(Date:9/18/2014)... , Sept. 18, 2014   MacPractice,s MacPractice ... Edition Complete EHR certification, which designates that the software ... Stage 1 and Stage 2 Meaningful Use measures required ... Reinvestment Act (ARRA).  MacPractice MD MU version 5.0 was ... , an Office of the National Coordinator-Authorized Certification Body ...
Breaking Medicine Technology:Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3Sugar Alcohols - Global Strategic Business Report 201 2Sugar Alcohols - Global Strategic Business Report 201 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5
... 2, 2011 Doctors should consider using catheterization as ... in diagnosing children with heart defects, according to a ... (Logo: http://photos.prnewswire.com/prnh/20100222/AHSALOGO ) A catheter is ... and used in procedures such as angiography, in which ...
... Lpath, Inc. (OTCBB: LPTN), the category leader ... President and CEO, will present at RetailInvestorConferences.com.DATE: ... EDTLINK: , www.retailinvestorconferences.com >Click the red "register/ ... interactive online event where investors are invited to ...
Cached Medicine Technology:Catheterization Recommended for Treating Pediatric Heart Conditions 2Catheterization Recommended for Treating Pediatric Heart Conditions 3Lpath, Inc. CEO to Present Live, Online at RetailInvestorConferences.com on May 5th 2Lpath, Inc. CEO to Present Live, Online at RetailInvestorConferences.com on May 5th 3
(Date:9/18/2014)... 2014 Alexandria, VA — The ... 10 more communities have joined the growing ranks of ... accreditation. The decisions bring the number of governmental public ... is the non-profit organization that administers the national public ... the health of the public by advancing the quality ...
(Date:9/18/2014)... THURSDAY, Sept. 18, 2014 (HealthDay News) -- Exposure to ... a new study. Hearing different languages in ... and willing to learn from people who are different ... that children, like adults, are often biased against interacting ... them," said Amanda Woodward, a University of Chicago psychology ...
(Date:9/18/2014)... 2014 (HealthDay News) -- Older people become more physically ... the balance of stress hormones during bereavement changes with ... who are grieving are more likely to have weakened ... "During the difficult weeks and months after loss, we ... most abundant type of white blood cell and as ...
(Date:9/18/2014)... September 18, 2014 "Medical staff need ... while also maintaining the patient's privacy," said one of ... this idea in order to supply caregivers with the ... They created a prototype for The Helper to make ... staff to turn patient onto his or her side. ...
(Date:9/18/2014)... Luis Obispo, CA (PRWEB) September 18, 2014 ... Bootie introduced their newest, patent pending bunion splint to ... As one loyalist, Rosa, wrote: "I was absolutely delighted. It ... I honestly forget I am wearing them. THANK YOU FOR ... recently introduced design by saying, "The hole used to slip ...
Breaking Medicine News(10 mins):Health News:Ten More Communities Reaping Benefits of National Accreditation 2Health News:Ten More Communities Reaping Benefits of National Accreditation 3Health News:Ten More Communities Reaping Benefits of National Accreditation 4Health News:Study: Exposure to Diversity Might Boost Baby's Social Skills 2Health News:Grief Can Weigh on Immune System in Older Folks, Study Says 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 2Health News:Feedback for the New Bunion Bootie Design Feedback is Already Pouring In, and Bunion Sufferers Love It 3
... release of the first long-range plan for tackling digestive ... each year. , Opportunities and Challenges in Digestive Diseases ... describes the impact of diseases ranging from foodborne infections ... for research over the next 10 years. The report ...
... BOTHELL, Wash., April 2 SCOLR Pharma, Inc. ... of HealthPro BioVentures LLC ("HealthPro"), a life sciences ... financial advisor in connection with the evaluation of ... strategic partners."We are excited about HealthPro joining our ...
... may work better than eating less, study finds , , THURSDAY, ... weight, cutting back on the calories in sugar-sweetened drinks, rather ... who found that cutting back on calories from sugary beverages ... nearly two-and-a-half pounds of lost weight over 18 months. ...
... Health Care has appointed a nationally recognized ... president of cancer services. (Logo: http://www.newscom.com/cgi-bin/prnh/20090303/CG78204LOGO-b ... Children,s Research Hospital in Memphis, where he served ... domestic affiliates. Prior to that, he was chief ...
... Medical Systems (NYSE: VAR ) announced today that ... noon through 2 p.m. on May 7, 2009 in Boston ... Lafayette. Management presentations will cover financial performance through the ... opportunities in markets for oncology systems, x-ray imaging, and security ...
... Researchers at UT Southwestern Medical Center have shed ... process important information. , Researchers found in a study ... molecules used by nerve cells to communicate with one ... and changes brain-cell circuitry to process important information differently ...
Cached Medicine News:Health News:NIH releases the first research plan to reduce the burden of digestive diseases 2Health News:NIH releases the first research plan to reduce the burden of digestive diseases 3Health News:SCOLR Pharma, Inc. Announces Engagement of HealthPro as Financial Advisor 2Health News:Fewer Sugary Drinks Key to Weight Loss 2Health News:Fewer Sugary Drinks Key to Weight Loss 3Health News:Nationally Recognized Oncologist to Lead Aurora Health Care's Cancer Services 2Health News:Nationally Recognized Oncologist to Lead Aurora Health Care's Cancer Services 3Health News:Varian Medical Systems Schedules Mid-Year Review With Investors in Boston 2Health News:UT Southwestern researchers reveal how the brain processes important information 2
Baby Weitlaner retractor, blunt, 4"....
Bruns (Volkmann) bone curette, with Novotex plastic handle (autoclavable in autoclave up to 143C by 3 bar), 9, oval....
15" overall length, 5" handle....
15" overall length, 9" handle....
Medicine Products: